《中国高血压防治指南(2024年修订版)》解读  

Interpretation of Chinese Guidelines for the Prevention and Treatment of Hypertension(Revised 2024 Edition)

作　　者：马志毅 MA Zhiyi(Department of Cardiology,Tsinghua University Affiliated Beijing Tsinghua Changgung Hospital,Beijing 102218,China)

机构地区：[1]清华大学附属北京清华长庚医院心血管内科,北京市102218

出　　处：《实用心脑肺血管病杂志》2025年第1期1-7,共7页Practical Journal of Cardiac Cerebral Pneumal and Vascular Disease

摘　　要：《中国高血压防治指南(2024年修订版)》编写过程历时2年余,专家组在细致整理最新研究成果的基础上,广泛征求了百余位专家学者的意见与建议,该指南凝聚了我国高血压领域多个学术团体及专家学者的心血和智慧,其中更新、新增的内容众多,从高血压的流行病学、临床研究的历史沿革角度出发,对高血压的诊断、治疗、管理提出了最新的推荐建议,并对高血压领域未来发展方向提出了研究展望。本文重点介绍了其在高血压诊断标准、血压测量方法、高血压发病的危险因素与高血压患者心血管预后的危险因素、高血压靶器官损伤的中国标准、高血压治疗(包括改善生活方式、降压药物治疗、器械治疗、中医药治疗)、高血压的特殊表型等方面的更新内容。The compilation process of the Chinese Guidelines for the Prevention and Treatment of Hypertension(Revised 2024 Edition)took more than 2 years.On the basis of carefully organizing the latest research results,the expert group extensively solicited opinions and suggestions from more than 100 experts and scholars.This guide embodies the efforts and wisdom of multiple academic groups,experts,and scholars in the field of hypertension in China.It contains numerous updated and newly added content,and provides the latest recommendations for the diagnosis,treatment,and management of hypertension from the perspective of the epidemiology and clinical research history of hypertension.It also offers research prospects for the future development direction of hypertension.This article focuses on the updated content of diagnostic criteria for hypertension,blood pressure measurement methods,risk factors for hypertension and cardiovascular prognosis in hypertensive patients,Chinese standards for target organ damage in hypertension,hypertension treatment(including lifestyle improvement,antihypertensive drug treatment,mechanical treatment,traditional Chinese medicine treatment),and special phenotypes of hypertension in the guideline.

关 键 词：高血压 中国 指南 

分 类 号：R544.1[医药卫生—心血管疾病]